RCM
TWST icon

Riverhead Capital Management’s Twist Bioscience TWST Stock Holding History

Riverhead Capital Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$195K Buy
+8,173
New +$238K 0.01% 1146

Other funds holding TWST

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Riverhead Capital Management's TWST Position: Q3 2019 in Review

Riverhead Capital Management opened a new position in Twist Bioscience (TWST) in Q3 2019: 8,173 shares worth $195K. The stake represents 0.01% of the portfolio and ranks #1146 among its holdings.

84 funds tracked by Wall St. Rank hold TWST as of Q3 2019.

  • Riverhead Capital Management held 8,173 shares of Twist Bioscience worth $195K as of Q3 2019.
  • Twist Bioscience was a new Riverhead Capital Management position in Q3 2019.
  • Twist Bioscience made up 0.01% of Riverhead Capital Management's portfolio in Q3 2019, its #1146 holding.
  • 84 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.